Clinical trial

A Study to Compare Uliledlimab Combined With Sintilimab and Chemotherapy Versus Sintilimab Combined With Chemotherapy in Patients With Previously Untreated Locally Advanced Unresectable or Metastatic Non-small Cell Lung Cancer

NCT07005336

Drugs and interventions used in this trial

5 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention Uliledlimab Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Sintilimab Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Pemetrexed Normalized identity: pemetrexedView linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Gemcitabine Normalized identity: gemcitabineView linked drug · Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Cisplatin Or Carboplatin Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

A Study to Compare Uliledlimab Combined With Sintilimab and Chemotherapy Versus Sintilimab Combined With Chemotherapy in Patients With Previously Untreated Locally Advanced Unresectable or Metastatic Non-small Cell Lung Cancer

Design: INTERVENTIONAL · Status: ACTIVE NOT RECRUITING · Phase: PHASE2

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusACTIVE_NOT_RECRUITING

Study typeINTERVENTIONAL

Start date2025-01-09

PhasePHASE2

Conditions

Non Small Cell Lung Cancerunresolved

Interventions

UliledlimabDRUG

SintilimabDRUG

PemetrexedDRUG · verified · RxNorm: pemetrexed

GemcitabineDRUG · verified · RxNorm: gemcitabine

Cisplatin Or CarboplatinDRUG

Sponsors & collaborators

TJ Biopharma Co., Ltd.lead sponsor

Mapped research locations

BeijingChina1 ShanghaiChina1 ChengduChina1 WuhanChina1 ChongqingChina1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07005336 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.